Smoking Cessation With Varenicline, a Selective 42 Nicotinic Receptor Partial Agonist
Currently available smoking cessation therapies have limited success rates. Varenicline tartrate is a novel, selective nicotinic receptor partial agonist developed specifically for smoking cessation.
This entry was posted on Wednesday, August 16th, 2006 at 10:58 am and is filed under Smoking Cessation. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.